Selected research
Market Analysis & Forecast
Global Microbial Single-Cell Sequencing Market Analysis and Forecast 2026-2032
Market perspective
The global Microbial Single-Cell Sequencing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Microbial Single-Cell Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Microbial Single-Cell Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Microbial Single-Cell Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Microbial Single-Cell Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Microbial Single-Cell Sequencing include Illumina, 10x Genomics, Pacific Biosciences, Oxford Nanopore Technologies, Beijing Genomic Institute and MobiDrop, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Microbial Single-Cell Sequencing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Microbial Single-Cell Sequencing, also provides the revenue of main regions and countries. Of the upcoming market potential for Microbial Single-Cell Sequencing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Microbial Single-Cell Sequencing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Microbial Single-Cell Sequencing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Microbial Single-Cell Sequencing revenue, projected growth trends, production technology, application and end-user industry.
Microbial Single-Cell Sequencing Segment by Company
Illumina
10x Genomics
Pacific Biosciences
Oxford Nanopore Technologies
Beijing Genomic Institute
MobiDrop
Microbial Single-Cell Sequencing Segment by Type
Genome Sequencing
Transcriptome Sequencing
Metagenome Sequencing
Others
Microbial Single-Cell Sequencing Segment by Application
Food Industry
Environmental Monitoring
Pharmaceutical Industry
Microbial Single-Cell Sequencing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microbial Single-Cell Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Microbial Single-Cell Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microbial Single-Cell Sequencing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Microbial Single-Cell Sequencing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Microbial Single-Cell Sequencing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Microbial Single-Cell Sequencing revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Genome Sequencing
- Transcriptome Sequencing
- Metagenome Sequencing
- Others
Applications
- Food Industry
- Environmental Monitoring
- Pharmaceutical Industry
Companies covered
- Illumina
- 10x Genomics
- Pacific Biosciences
- Oxford Nanopore Technologies
- Beijing Genomic Institute
- MobiDrop
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Microbial Single-Cell Sequencing Market by Type
- 1.2.1 Global Microbial Single-Cell Sequencing Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Genome Sequencing
- 1.2.3 Transcriptome Sequencing
- 1.2.4 Metagenome Sequencing
- 1.2.5 Others
- 1.3 Microbial Single-Cell Sequencing Market by Application
- 1.3.1 Global Microbial Single-Cell Sequencing Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Food Industry
- 1.3.3 Environmental Monitoring
- 1.3.4 Pharmaceutical Industry
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Microbial Single-Cell Sequencing Market Dynamics
- 2.1 Microbial Single-Cell Sequencing Industry Trends
- 2.2 Microbial Single-Cell Sequencing Industry Drivers
- 2.3 Microbial Single-Cell Sequencing Industry Opportunities and Challenges
- 2.4 Microbial Single-Cell Sequencing Industry Restraints
3 Global Growth Perspective
- 3.1 Global Microbial Single-Cell Sequencing Market Perspective (2021-2032)
- 3.2 Global Microbial Single-Cell Sequencing Growth Trends by Region
- 3.2.1 Global Microbial Single-Cell Sequencing Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Microbial Single-Cell Sequencing Market Size by Region (2021-2026)
- 3.2.3 Global Microbial Single-Cell Sequencing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Microbial Single-Cell Sequencing Revenue by Players
- 4.1.1 Global Microbial Single-Cell Sequencing Revenue by Players (2021-2026)
- 4.1.2 Global Microbial Single-Cell Sequencing Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Microbial Single-Cell Sequencing Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Microbial Single-Cell Sequencing Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Microbial Single-Cell Sequencing Key Players Headquarters & Area Served
- 4.4 Global Microbial Single-Cell Sequencing Players, Product Type & Application
- 4.5 Global Microbial Single-Cell Sequencing Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Microbial Single-Cell Sequencing Market CR5 and HHI
- 4.6.3 2025 Microbial Single-Cell Sequencing Tier 1, Tier 2, and Tier 3
5 Microbial Single-Cell Sequencing Market Size by Type
- 5.1 Global Microbial Single-Cell Sequencing Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Microbial Single-Cell Sequencing Revenue by Type (2021-2032)
- 5.3 Global Microbial Single-Cell Sequencing Revenue Market Share by Type (2021-2032)
6 Microbial Single-Cell Sequencing Market Size by Application
- 6.1 Global Microbial Single-Cell Sequencing Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Microbial Single-Cell Sequencing Revenue by Application (2021-2032)
- 6.3 Global Microbial Single-Cell Sequencing Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Illumina
- 7.1.1 Illumina Company Information
- 7.1.2 Illumina Business Overview
- 7.1.3 Illumina Microbial Single-Cell Sequencing Revenue and Gross Margin (2021-2026)
- 7.1.4 Illumina Microbial Single-Cell Sequencing Product Portfolio
- 7.1.5 Illumina Recent Developments
- 7.2 10x Genomics
- 7.2.1 10x Genomics Company Information
- 7.2.2 10x Genomics Business Overview
- 7.2.3 10x Genomics Microbial Single-Cell Sequencing Revenue and Gross Margin (2021-2026)
- 7.2.4 10x Genomics Microbial Single-Cell Sequencing Product Portfolio
- 7.2.5 10x Genomics Recent Developments
- 7.3 Pacific Biosciences
- 7.3.1 Pacific Biosciences Company Information
- 7.3.2 Pacific Biosciences Business Overview
- 7.3.3 Pacific Biosciences Microbial Single-Cell Sequencing Revenue and Gross Margin (2021-2026)
- 7.3.4 Pacific Biosciences Microbial Single-Cell Sequencing Product Portfolio
- 7.3.5 Pacific Biosciences Recent Developments
- 7.4 Oxford Nanopore Technologies
- 7.4.1 Oxford Nanopore Technologies Company Information
- 7.4.2 Oxford Nanopore Technologies Business Overview
- 7.4.3 Oxford Nanopore Technologies Microbial Single-Cell Sequencing Revenue and Gross Margin (2021-2026)
- 7.4.4 Oxford Nanopore Technologies Microbial Single-Cell Sequencing Product Portfolio
- 7.4.5 Oxford Nanopore Technologies Recent Developments
- 7.5 Beijing Genomic Institute
- 7.5.1 Beijing Genomic Institute Company Information
- 7.5.2 Beijing Genomic Institute Business Overview
- 7.5.3 Beijing Genomic Institute Microbial Single-Cell Sequencing Revenue and Gross Margin (2021-2026)
- 7.5.4 Beijing Genomic Institute Microbial Single-Cell Sequencing Product Portfolio
- 7.5.5 Beijing Genomic Institute Recent Developments
- 7.6 MobiDrop
- 7.6.1 MobiDrop Company Information
- 7.6.2 MobiDrop Business Overview
- 7.6.3 MobiDrop Microbial Single-Cell Sequencing Revenue and Gross Margin (2021-2026)
- 7.6.4 MobiDrop Microbial Single-Cell Sequencing Product Portfolio
- 7.6.5 MobiDrop Recent Developments
8 North America
- 8.1 North America Microbial Single-Cell Sequencing Revenue (2021-2032)
- 8.2 North America Microbial Single-Cell Sequencing Revenue by Type (2021-2032)
- 8.2.1 North America Microbial Single-Cell Sequencing Revenue by Type (2021-2026)
- 8.2.2 North America Microbial Single-Cell Sequencing Revenue by Type (2027-2032)
- 8.3 North America Microbial Single-Cell Sequencing Revenue Share by Type (2021-2032)
- 8.4 North America Microbial Single-Cell Sequencing Revenue by Application (2021-2032)
- 8.4.1 North America Microbial Single-Cell Sequencing Revenue by Application (2021-2026)
- 8.4.2 North America Microbial Single-Cell Sequencing Revenue by Application (2027-2032)
- 8.5 North America Microbial Single-Cell Sequencing Revenue Share by Application (2021-2032)
- 8.6 North America Microbial Single-Cell Sequencing Revenue by Country
- 8.6.1 North America Microbial Single-Cell Sequencing Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Microbial Single-Cell Sequencing Revenue by Country (2021-2026)
- 8.6.3 North America Microbial Single-Cell Sequencing Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Microbial Single-Cell Sequencing Revenue (2021-2032)
- 9.2 Europe Microbial Single-Cell Sequencing Revenue by Type (2021-2032)
- 9.2.1 Europe Microbial Single-Cell Sequencing Revenue by Type (2021-2026)
- 9.2.2 Europe Microbial Single-Cell Sequencing Revenue by Type (2027-2032)
- 9.3 Europe Microbial Single-Cell Sequencing Revenue Share by Type (2021-2032)
- 9.4 Europe Microbial Single-Cell Sequencing Revenue by Application (2021-2032)
- 9.4.1 Europe Microbial Single-Cell Sequencing Revenue by Application (2021-2026)
- 9.4.2 Europe Microbial Single-Cell Sequencing Revenue by Application (2027-2032)
- 9.5 Europe Microbial Single-Cell Sequencing Revenue Share by Application (2021-2032)
- 9.6 Europe Microbial Single-Cell Sequencing Revenue by Country
- 9.6.1 Europe Microbial Single-Cell Sequencing Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Microbial Single-Cell Sequencing Revenue by Country (2021-2026)
- 9.6.3 Europe Microbial Single-Cell Sequencing Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Microbial Single-Cell Sequencing Revenue (2021-2032)
- 10.2 China Microbial Single-Cell Sequencing Revenue by Type (2021-2032)
- 10.2.1 China Microbial Single-Cell Sequencing Revenue by Type (2021-2026)
- 10.2.2 China Microbial Single-Cell Sequencing Revenue by Type (2027-2032)
- 10.3 China Microbial Single-Cell Sequencing Revenue Share by Type (2021-2032)
- 10.4 China Microbial Single-Cell Sequencing Revenue by Application (2021-2032)
- 10.4.1 China Microbial Single-Cell Sequencing Revenue by Application (2021-2026)
- 10.4.2 China Microbial Single-Cell Sequencing Revenue by Application (2027-2032)
- 10.5 China Microbial Single-Cell Sequencing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Microbial Single-Cell Sequencing Revenue (2021-2032)
- 11.2 Asia Microbial Single-Cell Sequencing Revenue by Type (2021-2032)
- 11.2.1 Asia Microbial Single-Cell Sequencing Revenue by Type (2021-2026)
- 11.2.2 Asia Microbial Single-Cell Sequencing Revenue by Type (2027-2032)
- 11.3 Asia Microbial Single-Cell Sequencing Revenue Share by Type (2021-2032)
- 11.4 Asia Microbial Single-Cell Sequencing Revenue by Application (2021-2032)
- 11.4.1 Asia Microbial Single-Cell Sequencing Revenue by Application (2021-2026)
- 11.4.2 Asia Microbial Single-Cell Sequencing Revenue by Application (2027-2032)
- 11.5 Asia Microbial Single-Cell Sequencing Revenue Share by Application (2021-2032)
- 11.6 Asia Microbial Single-Cell Sequencing Revenue by Country
- 11.6.1 Asia Microbial Single-Cell Sequencing Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Microbial Single-Cell Sequencing Revenue by Country (2021-2026)
- 11.6.3 Asia Microbial Single-Cell Sequencing Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Microbial Single-Cell Sequencing Revenue (2021-2032)
- 12.2 SAMEA Microbial Single-Cell Sequencing Revenue by Type (2021-2032)
- 12.2.1 SAMEA Microbial Single-Cell Sequencing Revenue by Type (2021-2026)
- 12.2.2 SAMEA Microbial Single-Cell Sequencing Revenue by Type (2027-2032)
- 12.3 SAMEA Microbial Single-Cell Sequencing Revenue Share by Type (2021-2032)
- 12.4 SAMEA Microbial Single-Cell Sequencing Revenue by Application (2021-2032)
- 12.4.1 SAMEA Microbial Single-Cell Sequencing Revenue by Application (2021-2026)
- 12.4.2 SAMEA Microbial Single-Cell Sequencing Revenue by Application (2027-2032)
- 12.5 SAMEA Microbial Single-Cell Sequencing Revenue Share by Application (2021-2032)
- 12.6 SAMEA Microbial Single-Cell Sequencing Revenue by Country
- 12.6.1 SAMEA Microbial Single-Cell Sequencing Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Microbial Single-Cell Sequencing Revenue by Country (2021-2026)
- 12.6.3 SAMEA Microbial Single-Cell Sequencing Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst